|
CN110760007A
|
|
CD7-CAR-T cell and preparation and application thereof
|
|
CN110218702A
|
|
Target the immunocyte combination and its application of CD138 and CD19
|
|
CN109593134A
|
|
The Humanized monoclonal antibodies and its preparation of anti-CD20
|
|
CN109593137A
|
|
The building and application of the novel C D20-CAR carrier of anti-CD 20 antibodies
|
|
CN109652379A
|
|
The NK-92MI cell of CD7 Chimeric antigen receptor modification and its application
|
|
CN109651509A
|
|
The humanization monoclonal antibody and its preparation of anti-CD20
|
|
CN109879966A
|
|
Humanization design and expression verifying based on source of mouse CD19 antibody
|
|
CN109575143A
|
|
Bispecific CD20-CD19-CAR and its application
|
|
CN109970849A
|
|
The application of zkscan3 gene or its protein inhibitor in oncotherapy
|
|
CN109432429A
|
|
Application of the PD1 molecule inhibitor in T lymphocyte leukemia treating
|
|
CN110054698A
|
|
The building and application of the novel C D19-CAR carrier of anti-CD 19 antibodies
|
|
CN108276495A
|
|
Target the NK92MI cells and T cell and its preparation method and application that CSF1R Chimeric antigen receptors are modified
|
|
CN108060137A
|
|
The NK92 cells of IL7 and IL21 modifications, preparation method and applications
|
|
CN109422814A
|
|
A kind of NK cell, preparation method and its application of anti-La/SSB mosaic antigen modification
|
|
WO2016112855A1
|
|
Anti-cd19 monoclonal antibody and preparation method therefor
|
|
CN104004095A
|
|
CD7 nano antibody, coded sequence and application thereof
|
|
CN103114070A
|
|
Application method of single-cell separator
|
|
CN103160428A
|
|
Unicell separator
|
|
CN103013906A
|
|
Biological membrane and preparation method and application thereof
|
|
CN102590512A
|
|
Kit for mammary cancer individual administration testing and using method thereof
|
